The global spinal cord stimulator market is set to grow at a compound annual growth rate of 6.4 percent through 2027, according to a Future Market Insights report.
Spinal Tech
InVivo Therapeutics tapped Richard Toselli, MD, to serve as acting CEO.
Ampio Pharmaceuticals' Ampion, used to treat knee osteoarthritis, exceeded Phase 3 clinical trial standards set by the Osteoarthritis Research Society International.
Here are 13 key notes on orthopedic and spine device companies from the past week.
Wright Medical Group acquired a software-based solutions developer for preoperative planning of shoulder replacement surgery.
Advertisement
NuVasive appointed a new executive to lead its global surgeon education platform.
The global orthopedic devices market is set to reach $41.2 billion in 2019, based on a Transparency Market Research report, according to The Global Health News.
Stimwave named Jim Surek its first chief commercial officer and appointed Konstantin Slavin, MD, to its medical board of advisors.
The global spinal fusion market is anticipated to grow at a compound annual growth rate of 5.4 percent through 2027, according to a Future Market Insights report.
New York City-based Hospital for Special Surgery and pSivida partnered to create a implant that improves knee osteoarthritis pain.